AIM: To determine the clinical effects and complications of transjugular intrahepatic portosystemic shunt (TIPS) for portal hypertension due to cirrhosis. METHODS: Two hundred and eighty patients with portal hypertension due to cirrhosis who underwent TIPS were retrospectively evaluated. Portal trunk pressure was measured before and after surgery. The changes in hemodynamics and the condition of the stent were assessed by ultrasound and the esophageal and fundic veins observed endoscopically. RESULTS: The success rate of TIPS was 99.3%. The portal trunk pressure was 26.8 ± 3.6 cmH2O after surgery and 46.5 ± 3.4 cmH2O before surgery (P < 0.01). The velocity of blood flow in the portal vein increased. The internal diameters of the portal and splenic veins were reduced. The short-term hemostasis rate was 100%. Esophageal varices disappeared completely in 68% of patients and were obviously reduced in 32%. Varices of the stomach fundus disappeared completely in 80% and were obviously reduced in 20% of patients. Ascites disappeared in 62%, were markedly reduced in 24%, but were still apparent in 14% of patients. The total effective rate of ascites reduction was 86%. Hydrothorax completely disappeared in 100% of patients. The incidence of post-operative stent stenosis was 24% at 12 mo and 34% at 24 mo. The incidence of post-operative hepatic encephalopathy was 12% at 3 mo, 17% at 6 mo and 19% at 12 mo. The incidence of post-operative recurrent hemorrhage was 9% at 12 mo, 19% at 24 mo and 35% at 36 mo. The cumulative survival rate was 86% at 12 mo, 81% at 24 mo, 75% at 36 mo, 57% at 48 mo and 45% at 60 mo. CONCLUSION: TIPS can effectively lower portal hypertension due to cirrhosis. It is significantly effective for hemorrhage of the digestive tract due to rupture of esophageal and fundic veins and for ascites and hydrothorax caused by portal hypertension.
AIM: To determine the clinical effects and complications of transjugular intrahepatic portosystemic shunt (TIPS) for portal hypertension due to cirrhosis. METHODS: Two hundred and eighty patients with portal hypertension due to cirrhosis who underwent TIPS were retrospectively evaluated. Portal trunk pressure was measured before and after surgery. The changes in hemodynamics and the condition of the stent were assessed by ultrasound and the esophageal and fundic veins observed endoscopically. RESULTS: The success rate of TIPS was 99.3%. The portal trunk pressure was 26.8 ± 3.6 cmH2O after surgery and 46.5 ± 3.4 cmH2O before surgery (P < 0.01). The velocity of blood flow in the portal vein increased. The internal diameters of the portal and splenic veins were reduced. The short-term hemostasis rate was 100%. Esophageal varices disappeared completely in 68% of patients and were obviously reduced in 32%. Varices of the stomach fundus disappeared completely in 80% and were obviously reduced in 20% of patients. Ascites disappeared in 62%, were markedly reduced in 24%, but were still apparent in 14% of patients. The total effective rate of ascites reduction was 86%. Hydrothorax completely disappeared in 100% of patients. The incidence of post-operative stent stenosis was 24% at 12 mo and 34% at 24 mo. The incidence of post-operative hepatic encephalopathy was 12% at 3 mo, 17% at 6 mo and 19% at 12 mo. The incidence of post-operative recurrent hemorrhage was 9% at 12 mo, 19% at 24 mo and 35% at 36 mo. The cumulative survival rate was 86% at 12 mo, 81% at 24 mo, 75% at 36 mo, 57% at 48 mo and 45% at 60 mo. CONCLUSION: TIPS can effectively lower portal hypertension due to cirrhosis. It is significantly effective for hemorrhage of the digestive tract due to rupture of esophageal and fundic veins and for ascites and hydrothorax caused by portal hypertension.
Authors: Christophe Bureau; Juan Carlos Garcia-Pagan; Philippe Otal; Gilles Pomier-Layrargues; Valérie Chabbert; Carlos Cortez; Pierre Perreault; Jean Marie Péron; Juan G Abraldes; Louis Bouchard; José Ignacio Bilbao; Jaume Bosch; Hervé Rousseau; Jean Pierre Vinel Journal: Gastroenterology Date: 2004-02 Impact factor: 22.682
Authors: D Azoulay; D Castaing; P Majno; F Saliba; P Ichaï; A Smail; V Delvart; M Danaoui; D Samuel; H Bismuth Journal: J Hepatol Date: 2001-11 Impact factor: 25.083
Authors: K A Brensing; J Textor; J Perz; P Schiedermaier; P Raab; H Strunk; H U Klehr; H J Kramer; U Spengler; H Schild; T Sauerbruch Journal: Gut Date: 2000-08 Impact factor: 23.059
Authors: Dhiraj Tripathi; Ahmed Helmy; Kim Macbeth; Sherzad Balata; Hock F Lui; Adrian J Stanley; Doris N Redhead; Peter C Hayes Journal: Eur J Gastroenterol Hepatol Date: 2004-01 Impact factor: 2.566
Authors: Klaus A Hausegger; Franz Karnel; Buriana Georgieva; Josef Tauss; Horst Portugaller; Hannes Deutschmann; Andrea Berghold Journal: J Vasc Interv Radiol Date: 2004-03 Impact factor: 3.464
Authors: Leigh C Casadaban; Ahmad Parvinian; Jeet Minocha; Janesh Lakhoo; Christopher W Grant; Charles E Ray; M Grace Knuttinen; James T Bui; Ron C Gaba Journal: Dig Dis Sci Date: 2014-10-15 Impact factor: 3.199
Authors: Gian Luigi Natali; Giulia Cassanelli; Guglielmo Paolantonio; George Koshy Parapatt; Lorenzo Maria Gregori; Massimo Rollo Journal: Pediatr Radiol Date: 2022-09-19
Authors: Sara Santos; Eduardo Dantas; Filipe Veloso Gomes; José Hugo Luz; Nuno Vasco Costa; Tiago Bilhim; Filipe Calinas; Américo Martins; Élia Coimbra Journal: GE Port J Gastroenterol Date: 2020-06-09